SSRIs Associate With Most Favorable Treatment Profile for Panic Disorders
Researchers from Mahidol University in Thailand searched publication databases through June 2021 for studies of interventions for the treatment of panic disorders.
Researchers from Mahidol University in Thailand searched publication databases through June 2021 for studies of interventions for the treatment of panic disorders.
The study aimed to identify medication classes and specific SSRIs that provide high rates of remission as well as a low risk of adverse events when used in the treatment of panic disorder with or without agoraphobia.
Investigators analyzed data from the Happiness and Health Study of 2,263 students at 10 public high schools in Los Angeles, California.
In a recent survey, more than half the college students with ADHD had at least 1 psychiatric disorder. The recent WHO World Mental Health Survey of college students assessed comorbidities in more than 15,000 college freshmen across 9 countries.
Researchers conducted a meta-analysis of 181 publications that contrasted the neural activity of subjects with anxiety with subjects in control groups or healthy subjects in a safe condition with healthy subjects in an unpredictable-threat condition.
59% of Americans report that COVID-19 is affecting their daily lives, and 36% of respondents to the poll say that COVID-19 is taking a toll on their mental health.
Heart rate variability factors may predict therapeutic response in patients with major depressive disorder and panic disorder.
Palo Alto Health Sciences announced that the FDA has granted clearance to Freespira, a new digital therapeutic for the treatment of PTSD.
Patients who respond to panic-focused psychotherapy appear to maintain their improvements following treatment termination.
Therapeutic response to antidepressants is highly variable, which may be partially due to associated side effects.